{"abstract": "The talks between the two drug makers continue to center on the possible use of a contingent value right, a deal mechanism that allows for additional payouts if Genzyme hits certain milestones.", "web_url": "https://dealbook.nytimes.com/2011/01/07/sanofi-and-genzyme-keep-talking-over-potential-deal/", "snippet": "The talks between the two drug makers continue to center on the possible use of a contingent value right, a deal mechanism that allows for additional payouts if Genzyme hits certain milestones.", "lead_paragraph": "Jan. 9, 4:03 p.m. | Updated Sanofi-Aventis confirmed on Sunday that it was in discussions with Genzyme about potentially using contingent value rights to bolster its current takeover offer for the pharmaceutical company.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi-Genzyme Deal Talks Progress", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis S.A", "rank": 2, "major": "N"}], "pub_date": "2011-01-08T01:36:01+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/74db6375-908b-53bd-bec7-1975b6cb5fe7", "word_count": 275, "uri": "nyt://article/74db6375-908b-53bd-bec7-1975b6cb5fe7"}